CEO pay benchmark · $10B – $200B
Large-cap Pharmaceutical Preparations CEO salary
The median CEO compensation at large-cap companies in the pharmaceutical preparations industry is $13,313,010. That is 30% higher than the median across all pharmaceutical preparations companies in our benchmark.
Median CEO pay
$13.3M
Typical range
$10.0M–$16.3M
Companies
12
Average pay ratio
5:1
Vs. full industry
+30%
Size effect
How this group compares with the full industry
The same compensation measures are shown side by side, so the company-size difference is visible without mixing in another dataset.
| Measure | Large-cap | All Pharmaceutical Preparations |
|---|---|---|
| Companies | 12 | 37 |
| Median CEO pay | $13,313,010 | $10,278,620 |
| Average CEO pay | $13,661,794 | $11,050,380 |
| Middle 50% range | $10.0M–$16.3M | $7.9M–$14.5M |
| Average pay ratio |
Company appendix
Highest CEO pay in this peer group
Up to ten of the highest-paid CEOs in this benchmark, ordered by total annual compensation. Open any company for its full pay breakdown.
| Company | CEO | Total compensation | Market cap |
|---|---|---|---|
| Roivant Sciences Ltd.ROIV | Eric Venker | $24.4M | $26.2B |
| ABBOTT LABORATORIESABT | Robert B. Ford | $24.2M | $177.1B |
| MADRIGAL PHARMACEUTICALS, INC.MDGL |
Nearby peer groups